Atairos Partners GP Inc. Makes New Investment in Clarivate Plc (NYSE:CLVT)

Atairos Partners GP Inc. bought a new position in Clarivate Plc (NYSE:CLVT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 3,465,000 shares of the company's stock, valued at approximately $17,602,000. Clarivate accounts for about 35.4% of Atairos Partners GP Inc.'s holdings, making the stock its 2nd largest holding. Atairos Partners GP Inc. owned about 0.49% of Clarivate at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Clarkston Capital Partners LLC grew its holdings in Clarivate by 8.1% during the 4th quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company's stock valued at $359,328,000 after buying an additional 5,319,535 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Clarivate by 53.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock valued at $141,107,000 after purchasing an additional 9,691,104 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its position in Clarivate by 14.4% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock worth $53,333,000 after purchasing an additional 1,323,329 shares during the last quarter. Perpetual Ltd lifted its position in Clarivate by 24.6% during the fourth quarter. Perpetual Ltd now owns 9,192,680 shares of the company's stock valued at $46,699,000 after purchasing an additional 1,816,936 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Clarivate by 6.6% in the 4th quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company's stock worth $44,454,000 after buying an additional 538,907 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company's stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada restated a "sector perform" rating and set a $6.00 target price on shares of Clarivate in a research report on Thursday, February 20th.

Clarivate Trading Up 0.8 %

CLVT stock traded up $0.04 during mid-day trading on Friday, reaching $4.33. 4,860,607 shares of the stock traded hands, compared to its average volume of 5,221,834. The business has a 50-day moving average price of $3.87 and a two-hundred day moving average price of $4.84. The stock has a market capitalization of $2.98 billion, a PE ratio of -4.51 and a beta of 1.48. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.88 and a current ratio of 0.87. Clarivate Plc has a one year low of $3.04 and a one year high of $7.30.

Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.02. Clarivate had a negative net margin of 24.90% and a positive return on equity of 9.10%. The business had revenue of $593.70 million during the quarter, compared to the consensus estimate of $574.03 million. During the same quarter last year, the firm earned $0.14 earnings per share. The firm's quarterly revenue was down 4.4% compared to the same quarter last year. Equities research analysts expect that Clarivate Plc will post 0.63 EPS for the current year.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.